Stay updated on Pembrolizumab for Metastatic TNBC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Metastatic TNBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Metastatic TNBC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The study record for the completed KEYNOTE-086 pembrolizumab trial is displayed, including its design, participant criteria, outcome measures, and supporting documents.
    Difference
    53%
    Check dated 2026-11-08T23:10:59.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changes from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden response instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-01T23:16:49.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A sitewide notice appears at the top of the page announcing NIH website updates and a terminology transition from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-25T22:34:22.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer revision marker changed from v3.7.1 to v3.7.2 on the ClinicalTrials.gov error page.
    Difference
    0.2%
    Check dated 2026-10-18T22:49:03.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T23:06:19.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error page, indicating the study record is temporarily inaccessible. The site chrome (header/footer) remains visible while the 403 message is shown instead of the study details.
    Difference
    19%
    Check dated 2026-09-20T20:35:50.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Metastatic TNBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Metastatic TNBC Clinical Trial page.